Brian Dawson
Corporate Officer/Principal chez Hemoglobin Oxygen Therapeutics LLC
Profil
Brian Dawson currently works at Hemoglobin Oxygen Therapeutics LLC, as Senior Director-Process Development from 2014.
Mr. Dawson also formerly worked at Biopure Corp., as Director-Operations and OPK Biotech LLC, as Director-Operations.
Mr. Dawson received his undergraduate degree from Massachusetts College of Liberal Arts.
Postes actifs de Brian Dawson
| Sociétés | Poste | Début |
|---|---|---|
Hemoglobin Oxygen Therapeutics LLC
 Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Corporate Officer/Principal | 01/01/2014 |
Anciens postes connus de Brian Dawson
| Sociétés | Poste | Fin |
|---|---|---|
OPK Biotech LLC
 OPK Biotech LLC Pharmaceuticals: MajorHealth Technology OPK Biotech LLC is an American company that manufactures intravenous pharmaceuticals. | Directeur des opérations | - |
Biopure Corp.
 Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Directeur des opérations | - |
Formation de Brian Dawson
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Hemoglobin Oxygen Therapeutics LLC
Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Health Technology |
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
OPK Biotech LLC
OPK Biotech LLC Pharmaceuticals: MajorHealth Technology OPK Biotech LLC is an American company that manufactures intravenous pharmaceuticals. | Health Technology |
